Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
69.12
-1.16 (-1.65%)
At close: May 22, 2026, 4:00 PM EDT
67.88
-1.25 (-1.80%)
After-hours: May 22, 2026, 7:39 PM EDT

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $194.52M in the quarter ending March 31, 2026, with 66.78% growth. This brings the company's revenue in the last twelve months to $579.96M, up 355.17% year-over-year. In the year 2025, BridgeBio Pharma had annual revenue of $502.08M with 126.26% growth.

Revenue (ttm)
$579.96M
Revenue Growth
+355.17%
P/S Ratio
23.34
Revenue / Employee
$691,249
Employees
839
Market Cap
13.54B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025502.08M280.17M126.26%
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 201940.56M--
Dec 31, 2018---
Dec 31, 2017---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jazz Pharmaceuticals4.44B
Genmab3.90B
BioMarin Pharmaceutical3.24B
Exelixis2.38B
Madrigal Pharmaceuticals1.13B
Ionis Pharmaceuticals1.06B
Ascendis Pharma998.25M
Axsome Therapeutics708.24M
Revenue Rankings

BBIO News

More News